Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03191968 · ClinicalTrials.gov registry record · Phase 2
Prostate Cancer Survivors and Exercise and Behavioral Counseling
A Phase 2 study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT03191968: Completed Phase 2 study, sponsored by University of Illinois at Urbana-Champaign.
NCT03191968 is a Phase 2 study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 27 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03191968, a Phase 2 study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
This study will evaluate the feasibility of delivering a supervised physical activity program plus standard exercise counseling (SPA+EC) versus a supervised physical activity plus motivationally-enhanced behavioral counseling (SPA+BC) in prostate cancer survivors (PCS). Fifty participants (n=25) will be randomized to receiving SPA+EC or SPA+BC (n=25). We hypothesize that PCS receiving the SPA+BC intervention will result in greater increases in objectively-assessed physical activity compared with PCS receiving the SPA+EC intervention.
Primary Outcome
Objective Physical activity will be measured using an activity device, accelerometry (i.e., Actigraph GTX3+)
Interventions
- BEHAVIORAL Supervised Physical Activity Plus Behavioral Counseling
- BEHAVIORAL Supervised Physical Activity Plus Exercise Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2017-07-06 |
| Est. Completion | 2018-05-30 |
| Phase | Phase 2 |
What the finished NCT03191968 record still lists
NCT03191968 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which Supervised Physical Activity Plus Behavioral Counseling is the first listed.
NCT03191968 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03191968 about?
NCT03191968 is a clinical study titled "Prostate Cancer Survivors and Exercise and Behavioral Counseling". This study will evaluate the feasibility of delivering a supervised physical activity program plus standard exercise counseling (SPA+EC) versus a supervised physical activity plus motivationally-enhanced behavioral counseling (SPA+BC) in prostate cancer survivors (PCS). Fifty participants (n=25) wil...
What is the current status of trial NCT03191968?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2017-07-06. Estimated completion is 2018-05-30.
What interventions are being tested in trial NCT03191968?
The interventions under investigation include: Supervised Physical Activity Plus Behavioral Counseling (BEHAVIORAL), Supervised Physical Activity Plus Exercise Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT03191968?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03191968's enrollment target sits among peer trials
27 1697th of 2000 higher than 293 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI